Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body. Pancreatic cancer starts when cells in the pancreas start to grow out of control.
The Tissue Bank collects and stores tissue, blood, saliva and urine from people with pancreatic cancer and other diseases of the pancreas, alongside samples of blood, urine and saliva from first degree relatives of patient donors and other healthy volunteers.
While reserves are being built up, applications for samples will be invited from researchers at all the collaborating centres and those engaged in current and completed projects funded by Pancreatic Cancer Research Fund. The Tissue Bank will be open to applications from any researcher in the UK from year 3, and as stocks become sufficiently available, to international researchers.
|Find a clinical trial||Most people do not need to be screened for pancreatic cancer, and the tests available for screening frequently are complex, risky, expensive, or insensitive in the early phases of the cancer.|
|New to MyHealth?||Leaving a Lasting Legacy for a Loved One Bequests by Will There are many ways to leave a lasting legacy that will honor you, your loved one or a special friend. One of those is a Bequest through your Will.|
|Pancreatic cancer statistics | Cancer Research UK||Immunomodulators Oncolytic Virus Therapy Targeted antibodies are proteins produced by the immune system that can be customized to target specific markers on cancer cells, in order to disrupt cancerous activity, especially unrestrained growth.|
Researchers will be able to apply to access tissues alongside detailed information about the tumour type, grade and the anonymous donor's clinical history. We anticipate that around 1, new patients will donate their tumour tissue to the Tissue Bank each year.
All research data generated from the Tissue Bank samples will be fed back into a bespoke bioinformatics database and made freely available to the global research community. If you are a patient and want to find out more about donating to the Tissue Bank, please visit our main website.
We will be using information from your medical records in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after your information and using it properly.
Queen Mary University of London will keep identifiable information about you for 20 years after the study has finished. Your rights to access change or move your information are limited, as we need to manage your information in specific ways in order for the research to be reliable and accurate.
If you withdraw from the study, we will keep the information about you that we have already obtained. To safeguard your rights, we will use the minimum personally-identifiable information possible.
You can find out more about how we use your information at http:On Sept. 21, the Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, honored MIT’s commitment to pancreatic cancer research with the naming of the Lustgarten Laboratory for Pancreatic Cancer Research at MIT.
Research spotlight. A top scientist from the Knight Cancer Institute at Oregon Health & Science University is helping to lead a pancreatic cancer research dream team tasked with finding ways to use a patient’s own immune cells to eradicate their cancers.
Pancreatic Cancer "Cancer of the pancreas is a genetic disease that is the fifth most common cause of death in both men and women. Pancreatic cancer affects approximately 28, Americans each year, or five out of , people" (Mayo Clinic, ).
Founded in , the Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer.
In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Few survive more than five years after a diagnosis of pancreatic cancer, so medical researchers are eager to find ways to diagnose and treat it sooner.
A new study suggests the presence of certain. Pancreatic Cancer. The pancreatic cancer research team of the Discovery and Translation Labs at Mayo Clinic's Florida campus is led by Peter Storz, Ph.D., and Michael B. Wallace, M.D. Their research is focused on early detection, prevention and precision therapy.